SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-015248
Filing Date
2021-08-03
Accepted
2021-08-03 08:56:16
Documents
68
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q espr-20210630.htm   iXBRL 10-Q 1249845
2 EX-10.1 ex101-licenseandcollaborat.htm EX-10.1 652235
3 EX-10.2 ex102-amendedkoenigemploym.htm EX-10.2 74602
4 EX-31.1 espr-ex311x06302021.htm EX-31.1 11058
5 EX-31.2 espr-ex312x06302021.htm EX-31.2 11130
6 EX-32.1 espr-ex321x06302021.htm EX-32.1 7612
  Complete submission text file 0001628280-21-015248.txt   7038953

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20210630.xsd EX-101.SCH 51600
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20210630_cal.xml EX-101.CAL 51035
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20210630_def.xml EX-101.DEF 252629
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT espr-20210630_lab.xml EX-101.LAB 604690
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20210630_pre.xml EX-101.PRE 388682
12 EXTRACTED XBRL INSTANCE DOCUMENT espr-20210630_htm.xml XML 948685
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35986 | Film No.: 211138171
SIC: 2834 Pharmaceutical Preparations